[IKT] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
14-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -16.49%
YoY- -25.75%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
Revenue 0 80 0 328 38 124 -
PBT -5,778 -4,595 -4,495 -4,471 -671 -1,212 36.61%
Tax 0 46 0 -4,471 -664 -1,205 -
NP -5,778 -4,595 -4,495 -4,471 -671 -1,212 36.61%
Tax Rate - - - - - - -
Total Cost 5,778 4,675 4,495 4,800 708 1,337 33.96%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
NP Margin 0.00 -5,775.11 0.00 -1,361.26 -1,779.72 -974.37 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
EPS -0.65 -0.86 -1.06 -1.07 -0.49 -0.89 -6.08%
EPS Diluted -0.65 -0.86 -1.06 -1.07 -0.49 -0.89 -6.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.